We are monitoring the impact of COVID-19 on MEA Virology Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4935
Share on
Share on

MEA Virology Market Research Report – Segmented By Type, Application, End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4935
Pages: 140

The size of the Virology Market in the Middle East and Africa is projected to grow at a sluggish rate from 2021 to 2026.

The virology market in the Middle East and Africa is predicted to expand dramatically during the forecast period. A lot of things have supported its expansion. Various government agencies in the Middle East and Africa are promoting awareness about diseases such as the Zika virus, the flu, AIDS, Ebola, and sexually transmitted diseases (STDs). Public awareness programs on contagious viruses are another significant factor contributing to the growth of the virology market in the Middle East and Africa since they contribute to an increase in viral cases in the population. The virology market in MEA is continually adapting to the preventative and curative needs of the healthcare industry.

Several diseases need R&D for new applications, driving the market growth. Applications in virology are employed in a wide range of therapeutic and diagnostic processes, supporting market growth. The technological advancements, increased number of product releases, and higher investments in healthcare and research are further estimated to fuel the growth rate of the virology market in this region.

Maintaining the quality and safety requirements of viral control medications has long been a challenge, and it is expected to continue to do so during the forecast period. Furthermore, the market for antiviral drugs is projected to be constrained by tight regulatory processes. In addition, resistance to antiviral drugs and their adverse effects on novel treatment options have also been identified as affecting market growth.

This research report on the MEA virology market has been segmented and sub-segmented into the following categories.

By Type:

  • Diagnosing Test
  • Viral Infection Controlling Methods
  • Antiviral Chemotherapy
  • Interferons

By Application:

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Urinary Tract Infections
  • Eye Infections
  • CNS Infections
  • Sexually Transmitted Diseases
  • Perinatal Infections

By End-User:

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centres
  • Blood Banks
  • Pharmacies

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East and Africa have an untapped market, and key players are slowly expanding to this region which is the main reason for the growth of the market in this region. The virology market in the Middle East and Africa is moderately fragmented, with many well-established companies. As a result, the market for virology is quite competitive. To preserve a strong position in the market, participants employ several organic and inorganic approaches.

Virology is a key component of almost every country's healthcare system, including the UAE and Kuwait. It can be used for vaccine development, diagnostics, and therapy regimens, among other things. As a result, regional market participants are always using strategies such as product innovations and expansions to remain competitive in the global market.

The UAE and Kuwait spend a lot of money on healthcare and even set aside money for it in their budgets. Due to increased healthcare infrastructure and equipment, greater access to diagnostics, and the growing affordability of viral infection diagnostic tests, it is likely to have the highest CAGR throughout the forecast period.

KEY MARKET PLAYERS:

Boehringer Ingelheim Corporation, Merck and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche. are some key players in the Middle East and Africa Virology market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. OVERVIEW
    1. Executive Summary
    2. Key Inferences
  4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. MARKET SEGMENTATION
    1. Type
      1. Introduction
      2. Diagnosing Test
        1. DNA Viruses
        2. RNA Viruses
        3. Prions Diagnostic Test
        4. Other Viral Tests
      3. Viral Infection Controlling Methods
        1. Immunoprophylaxis
        2. Active Prophylaxis (Vaccines)
        3. Passive Prophylaxis
      4. Antiviral Chemotherapy
        1. Virucidal Agents
        2. Antiviral Agents
        3. Immunomodulators
      5.                    Interferons
        1. Cytokines
      6. Y-o-Y Growth Analysis, By Type
      7. Market Attractiveness Analysis, By Type                 
      8. Market Share Analysis, By Type
    2. Application           
      1. Introduction
      2. Skin and Soft Tissue Infections
      3. Respiratory Tract Infections
      4. GI Tract Infections
      5. Urinary Tract Infections
      6. Eye Infections
      7. CNS Infections
      8. Sexually Transmitted Diseases
      9. Perinatal Infections
      10. Y-o-Y Growth Analysis, By Application
      11. Market Attractiveness Analysis, By Application
      12. Market Share Analysis, By Application
    3. End User
      1. Introduction
      2. Hospitals
      3. Clinics
      4. Laboratories
      5. Diagnostic Centres
      6. Blood Banks
      7. Pharmacies
      8. Y-o-Y Growth Analysis, By End User
      9. Market Attractiveness Analysis, By End User
      10. Market Share Analysis, By End User
  6. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Middle East and Africa
      1. Introduction
      2. Middle East
      3. Africa
    3. STRATEGIC ANALYSIS
      1. PESTLE analysis
        1. Political
        2. Economic
        3. Social
        4. Technological
        5. Legal
        6. Environmental
    4. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  7. MARKET LEADERS' ANALYSIS
    1. Johnson & Johnson
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Abbott Laboratories
    3. GlaxoSmithKline plc
    4. Boehringer Ingelheim Corporation
    5. Merck and Co. Inc.
    6. Novartis International AG
    7. Siemens
    8. AstraZeneca AB
    9. Roche
  8. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  9. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  10. APPENDIX
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the MEA market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa Virology Market, By Type, From 2021 to 2026 (USD Million)
  2. Middle East and Africa Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East and Africa Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East and Africa Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East and Africa Interferons Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East and Africa Virology Market, By Application, From 2021 to 2026 (USD Million)
  7. Middle East and Africa Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East and Africa GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East and Africa Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East and Africa Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East and Africa CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East and Africa Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East and Africa Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East and Africa Virology Market, By End User, From 2021 to 2026 (USD Million)
  15. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East and Africa Clinics Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East and Africa Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East and Africa Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  19. Middle East and Africa Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  20. Middle East and Africa Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East Virology Market, By Type, From 2021 to 2026 (USD Million)
  22. Middle East Virology Market, By Application, From 2021 to 2026 (USD Million)
  23. Middle East Virology Market, By End User, From 2021 to 2026 (USD Million)
  24. Africa Virology Market, By Type, From 2021 to 2026 (USD Million)
  25. Africa Virology Market, By Application, From 2021 to 2026 (USD Million)
  26. Africa Virology Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample